{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:12:23Z","timestamp":1777349543951,"version":"3.51.4"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1428,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1365-2265.2011.04050.x","type":"journal-article","created":{"date-parts":[[2011,3,19]],"date-time":"2011-03-19T12:47:25Z","timestamp":1300538845000},"page":"592-595","source":"Crossref","is-referenced-by-count":5,"title":["What medical options should be considered for the treatment of primary hyperparathyroidism?"],"prefix":"10.1111","volume":"75","author":[{"given":"Mara J.","family":"Horwitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,4]]},"reference":[{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/jbmr.5650061409","article-title":"Epidemiology of primary hyperparathyroidism","volume":"6","author":"Melton","year":"1991","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.2008-1758","article-title":"Diagnosis of primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Eastell","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/cs0730659","article-title":"Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism","volume":"73","author":"Clemens","year":"1987","journal-title":"Clinical Science"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","article-title":"Vitamin D Status, seasonal variations, parathyroid adenoma weight and bone density in primary hyperparathyroidism","volume":"63","author":"Moosgaard","year":"2005","journal-title":"Clinical Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-08-0901","article-title":"Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D","volume":"161","author":"Tucci","year":"2009","journal-title":"European Journal of Endocrinology"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","article-title":"The effects of vitamin D insufficiency in patients with primary hyperparathyroidism","volume":"107","author":"Silverberg","year":"1999","journal-title":"American Journal of Medicine"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.surg.2008.06.032","article-title":"Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?","volume":"144","author":"Grubbs","year":"2008","journal-title":"Surgery"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12020-009-9211-1","article-title":"Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency","volume":"36","author":"Isidro","year":"2009","journal-title":"Endocrine"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2009-2384","article-title":"Skeletal effects of intervention of mild primary hyperparathyroidism: a meta analysis","volume":"95","author":"Sakaran","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/jc.2008-1757","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism revisited","volume":"94","author":"Khan","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1210\/jc.81.10.3487","article-title":"Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"81","author":"Guo","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2002-020667","article-title":"Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Rubin","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01623394","article-title":"Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women with primary hyperparathyroidism: a preliminary report","volume":"6","author":"Diamond","year":"1996","journal-title":"Osteoporosis International"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism","volume":"125","author":"Grey","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jc.2008-1762","article-title":"Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Khan","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term control of primary hyperparathyroidism in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1111\/j.1365-2265.2011.04050.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1210\/jc.2010-1221","article-title":"Cinacalcet HCL reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity","volume":"96","author":"Peacock","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2011.04050.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2265.2011.04050.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T22:16:27Z","timestamp":1625436987000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2011.04050.x"}},"subtitle":["Treatment of primary hyperparathyroidism"],"short-title":[],"issued":{"date-parts":[[2011,10,4]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04050.x","relation":{},"ISSN":["0300-0664"],"issn-type":[{"value":"0300-0664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,4]]}}}